G

Geneva University Hospitals | Infectious Diseases Division

Research site

(Unclaimed)

Location

HUG - Rue Gabriel Perret Gentil 4, Bldg C, 2nd Floor, Geneva, Geneva, Switzerland

Site insights

Top conditions

Top treatments

Concerta

Garamycin

Tarlatamab

Colistin

N-desmethylclobazam

Trimethoprim

Iron

Methicillin

BI 754091

Baloxavir

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 94 total trials

A Trial of Tarlatamab in Patients With Pretreated Extensive-stage Small Cell Lung Cancer (ES-SCLC) and ECOG PS 2 (START-lung)

START-lung is an international, multicentre, single-arm phase II trial. Protocol treatment consists of tarlatamab administered as an intravenous infu...

Begins enrollment in 2 months

Extensive Stage Lung Small Cell Cancer

Drug: Tarlatamab

Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer (KISIMA-01)

This is a multi-center, non-randomised Phase 1b study to evaluate the safety and tolerability of ATP128 alone or in combination with BI 754091 and of...

Active, not recruiting

Stage IV Rectal Cancer

Metastatic Colorectal Cancer

Drug: ATP128

Drug: BI 754091